Lee, Yeong-Yeh and Leow, Alex H-R and Chai, Pei-Fan and Raja Ali, Raja Affendi and Lee, Way-Seah and Goh, Khean-Lee (2021) Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology. JGH Open, 5 (1). pp. 11-19. ISSN 2397-9070, DOI https://doi.org/10.1002/jgh3.12469.
Full text not available from this repository.Abstract
Probiotics comprise a large group of microorganisms, which have different properties and thus confer different benefits. The use of probiotics has shown promising results in the management of diarrheal diseases. While the availability of probiotic products has flourished in the marketplace, there is limited guidance on the selection of probiotics for clinical use. This position paper is aimed at informing clinicians about the proper selection criteria of probiotics based on current evidence on strain-specific efficacy and safety for the management of diarrheal diseases. Members of the working group discussed issues on probiotic use in clinical practice, which were then drafted into statements. Literature to support or refute the statements were gathered through a search of medical literature from 2011 to 2020. Recommendations were formulated based on the drafted statements and evidence gathered, revised as necessary, and finalized upon agreement of all members. Twelve statements and recommendations were developed covering the areas of quality control in the manufacturing of probiotics, criteria for selection of probiotics, and established evidence for use of probiotics in diarrheal diseases in adults and children. Recommendations for the use of specific probiotic strains in clinical practice were categorized as proven and probable efficacy based on strength of evidence. Robust evidence is available to support the use of probiotics for diarrheal diseases in clinical practice. Based on the results obtained, we strongly advocate the careful evaluation of products, including manufacturing practices, strain-specific evidence, and contraindications for at-risk populations when choosing probiotics for use in clinical practice. © 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
| Item Type: | Article |
|---|---|
| Funders: | Biocodex (France), Servier Malaysia Sdn |
| Uncontrolled Keywords: | Cellular imaging;Dipolar dye;Fluorescent dye;Nanoprobe;Near-infrared emitting. |
| Subjects: | R Medicine R Medicine > RC Internal medicine |
| Divisions: | Faculty of Medicine |
| Depositing User: | Ms Zaharah Ramly |
| Date Deposited: | 28 Oct 2022 01:38 |
| Last Modified: | 28 Oct 2022 01:38 |
| URI: | http://eprints.um.edu.my/id/eprint/36019 |
Actions (login required)
 |
View Item |
